Apollomics's market cap is currently ―. The company's EPS TTM is $-2.799; its P/E ratio is -0.11; Apollomics is scheduled to report earnings on September 26, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Sep 22	Jun 22	Mar 22
Income Statement	-
Total Revenue	-	-	-	$ 0.00	$ 0.00
Gross Profit	-	-	-	-	-
EBIT	-	-	-	$ -383.85K	$ -389.37K
EBITDA	-	-	-	$ -383.85K	$ -389.37K
Net Income Common Stockholders	-	-	-	$ -236.99K	$ -355.96K
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 32.06M	$ 32.67M	-	$ 279.27K	$ 301.95K
Total Assets	$ 55.39M	$ 76.47M	-	$ 105.56M	$ 105.48M
Total Debt	$ 5.66M	$ 991.00K	$ 0.00	$ 0.00	$ 0.00
Net Debt	$ -26.39M	$ -31.68M	$ 0.00	$ -279.27K	$ -301.95K
Total Liabilities	$ 14.15M	$ 538.86M	-	$ 4.00M	$ 3.68M
Stockholders Equity	$ 41.23M	$ -462.39M	-	$ 101.56M	$ 101.80M
Cash Flow	-
Free Cash Flow	-	-	-	$ -71.66K	$ -297.01K
Operating Cash Flow	-	-	-	$ -71.66K	$ -297.01K
Investing Cash Flow	-	-	-	-	-
Financing Cash Flow	-	-	-	-	-

Currency in USD

Apollomics Earnings and Revenue History

Income Statement >

Apollomics Debt to Assets

Balance Sheet >

Apollomics Cash Flow

Cash Flow >

Apollomics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing